Dermatologic adverse events associated with amivantamab: A multicentre study

Journal of the European Academy of Dermatology and Venereology 2026 Open access

Read full text
Authors: Vasiliki Nikolaou, A. Mayor, V. Sibaud, Damien Giacchero, Davide Fattore, Zoé Apalla, P. Sollena, Michela Starace, Sònia Segura, Adi Nosrati, Ana Clara Torre, Julia Riganti
+19 more Pierre Grassi, Pascale Tomasini, Dimitra Koumaki, Océane Ducharme, Ryma Boujnah, Ioannis‐Alexios Koumprentziotis, Luca Rapparini, Lukas Kraehenbuehl, Azael Freites‐Martínez, Caroline Gaudy‐Marqueste, Chrysa Oikonomou, Katerina Grafanaki, Sofia Agelaki, Tanja Radevic, A. Charpidou, K. Peris, Elisabeth Lazaridou, Alexander Stratigos, Nausicaa Malissen
DOI: 10.1111/jdv.70360
Cited by: 5
References: 6

Abstract

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Fields of Study & Subjects

Chemotherapy-related skin toxicity Drug-Induced Adverse Reactions Colorectal Cancer Treatments and Studies

Publication details

Journal / source
Journal of the European Academy of Dermatology and Venereology
Publisher
Wiley
Volume
40
Issue
8
Pages
e692–e695
Publication date
11 February 2026
Language
EN